Document Detail


Treatment with Qing'E, a kidney-invigorating Chinese herbal formula, antagonizes the estrogen decline in ovariectomized mice.
MedLine Citation:
PMID:  20707715     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A Chinese herbal preparation, Qing'E formula (QEF), has been used clinically for treating osteoporosis in postmenopausal women by virtue of its kidney-invigorating function; however, no evidence base links QEF to estrogen replacement therapy. In this study, we undertake a characterization of estrogenic activity of QEF using an in vivo model of ovariectomized (OVX) mice together with in vitro studies with the MCF-7 cells for further molecular characterization. OVX mice were treated intragastrically with QEF at doses of 0.85, 1.7, and 3.4 g/kg per day for 4 weeks. QEF treatments restored the estrus cycle and demonstrated significant estrogenic activity, as indicated by reversal of uterine atrophy (six-fold increase in uterine weight), reduction in rectal temperature, and increased expression (1.6-fold) of estrogen receptors (ERs) in the uterus. Notably, the largest changes in these three parameters were found at the lowest dose. At the highest dose of QEF, significant changes were found in adrenal gland weight (30% increase), serum estradiol (E(2)) (60% increase), and luteinizing hormone (LH) (17% decrease) compared with untreated OVX controls. The data suggest estrogenic responses induced by QEF show tissue variation that reflects different affinities of ERs for QEF components. QEF could significantly induce luciferase expression (2.7-fold compared with control) from an estrogen response element luciferase reporter and induced expression of ERalpha and ERbeta (1.2-fold and 1.7-fold respectively) in MCF-7 cells. Both activities were inhibited 80-90% by the estrogen antagonist ICI 182,780. This study demonstrates that QEF activity is mediated through estrogenic components and provides an evidence base for QEF treatment of postmenopausal symptoms.
Authors:
Ying Xu; Zi-Jia Zhang; Fang Geng; Shi-bing Su; Kenneth N White; S W Annie Bligh; Christopher J Branford-White; Zheng-tao Wang
Related Documents :
17003025 - Genetics and hormones in testicular descent.
22968785 - Inhibition of neu-induced mammary carcinogenesis in transgenic mice expressing erΔ3, a...
18719025 - Estrogen actions in the male reproductive system involve estrogen response element-inde...
21743025 - Role of the fas/fasl system in a model of rsv infection in mechanically ventilated mice.
14725965 - Association between inflammation and nigral neuronal damage following striatal excitoto...
19549245 - Immune evasion during varicella zoster virus infection of keratinocytes.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Rejuvenation research     Volume:  13     ISSN:  1557-8577     ISO Abbreviation:  Rejuvenation Res     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-25     Completed Date:  2010-12-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101213381     Medline TA:  Rejuvenation Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  479-88     Citation Subset:  IM    
Affiliation:
The MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Glands / drug effects
Animals
Cell Line, Tumor
Dose-Response Relationship, Drug
Drugs, Chinese Herbal*
Estradiol / blood*
Estrus / drug effects
Female
Humans
Immunohistochemistry
Luteinizing Hormone / metabolism
Mice
Organ Size / drug effects
Ovariectomy*
Receptors, Estrogen / metabolism
Uterus / metabolism
Chemical
Reg. No./Substance:
0/Drugs, Chinese Herbal; 0/Receptors, Estrogen; 50-28-2/Estradiol; 9002-67-9/Luteinizing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the Un...
Next Document:  Immuno-positron emission tomography: shedding light on clinical antibody therapy.